Kidney Transplantation
Kidney Transplantation
Part of NephTimes
Advertisement
Victoria SochaKidney Transplantation | April 16, 2024
Few data are available on the association between primary kidney disease and donor relatedness with transplant outcomes.
Read More
Victoria SochaKidney Transplantation | April 11, 2024
Researchers compared the overall and site-specific risk of fracture among living kidney donors.
Charlotte RobinsonKidney Transplantation | March 28, 2024
The FDA granted Orphan Drug Designation for felzartamab to treat antibody-mediated rejection in kidney transplant recipients.
Victoria SochaKidney Transplantation | March 26, 2024
The EnAKT LKD trial was designed to target barriers preventing eligible patients from receiving a kidney transplant.
Charlotte RobinsonKidney Transplantation | March 25, 2024
Kidney transplant recipients are living longer, and their transplanted kidneys are lasting longer, researchers said.
Charlotte RobinsonKidney Transplantation | March 21, 2024
A Boston area man became the first to receive a genetically modified pig kidney via transplant.
Charlotte RobinsonKidney Transplantation | March 12, 2024
Authorities are investigating whether several nonprofit organ procurement organizations defrauded the US government.
Victoria SochaKidney Transplantation | March 12, 2024
Studies have suggested physical activity has beneficial effects on health-related outcomes in kidney transplant patients.
Victoria SochaKidney Transplantation | March 7, 2024
Researchers examined racial differences in rates of living donor kidney transplant, including center characteristics.
Charlotte RobinsonKidney Transplantation | March 4, 2024
The FDA gave orphan drug designation to UNI-494 for the prevention of delayed graft function in kidney transplant patients.
Charlotte RobinsonKidney Transplantation | March 4, 2024
The American Kidney Fund released its fourth annual report card ranking states' support of living organ donation.
Victoria SochaKidney Transplantation | February 22, 2024
Potential living kidney donors may be unprepared for possible negative outcomes following donation.
Victoria SochaKidney Transplantation | February 12, 2024
There was no association between kidneys from active COVID-19-positive donors procured in 2023 and higher odds of nonuse.
Victoria SochaKidney Transplantation | February 5, 2024
Metformin users had a lower risk of graft failure, even after accounting for the competing risk of all-cause mortality.
Victoria SochaKidney Transplantation | February 5, 2024
No recipient tumors had a histological type matching that of the donor brain tumor.
Victoria SochaKidney Transplantation | February 5, 2024
The actual burden of vaccine-preventable infections among recipients of solid organ transplants is unclear.
Victoria SochaKidney Transplantation | February 5, 2024
At 1 year after transplant, patient and graft survival was 100%.
Victoria SochaCOVID-19 and Kidney Disease | February 5, 2024
Results of an analysis to characterize the sequelae of COVID-19 infection among kidney transplant recipients.
Victoria SochaCOVID-19 and Kidney Disease | February 5, 2024
Participants were analyzed for antibodies to the SARS-CoV-2 spike protein receptor-binding domain.
Victoria SochaASN Kidney Week 2023 | February 5, 2024
Examining the role of neighborhood deprivation in assess to living donor kidney transplantation.
Advertisement
Advertisement
Advertisement
Latest News

April 19, 2024